The presence of funnel plot asymmetry also suggests potential publication bias, which warrants further scrutiny
Semaglutide Is the Better-Evidenced Agent Several randomized trials conducted between 2021 and 2025 showed semaglutide 1.02.4mg weekly produces roughly 1015% weight loss in PCOS patients over 612 months, with parallel improvements in menstrual cycle frequency, testosterone, sex hormone-binding globulin (SHBG), and HOMA-IR (a marker of insulin resistance)
"We believe these reports are a step forward in meeting an unmet need for a more informed and personalized approach to weight management," said study co-author Noura Abul-Husn, chief medical officer at the 23andMe Research Institute in California, in a press release
If you're exploring this route, our guide on how to get GLP-1 without insurance walks through the specifics
The form and protocol are individualized